Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer.
Taking the favoured mineral augment selenium doesn't let up the distinct possibility of lung cancer recurrence, a new study reveals. Lead father Dr Daniel D Karp, a professor in the worry of thoracic head and neck medical oncology at the University of Texas MD Anderson Cancer Center, is scheduled to backsheesh the discovery Saturday at the American Society of Clinical Oncology annual meeting, in Chicago relmus 8mg uses. "Several epidemiological and physical studies have long-suggested a bond between deficiency of selenium and cancer development," said Karp in a announcement release.

So "Interest and research escalated in the behindhand 1990s after a skin cancer and selenium study, published in 1996, found no advantage against the skin cancer, but did suggest an approximate 30 percent reduction of prostate and lung cancers international. Our lung cancer experiment with and another larger study for the prevention of prostate cancer evolved from that finding".